Cardiomyopathy, adult valve disease and heart failure in South America

E A Bocchi1, G Guimarães, F Tarasoutshi

  • 1Heart Institute (InCor), São Paulo University Medical School, São Paulo, Brazil. dcledimar@incor.usp.br

Insights

Cardiovascular diseases are a leading cause of death in South America, with heart failure (HF) being a major reason for hospitalization. Public health strategies must address Chagas disease and rheumatic fever to reduce HF burden.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Cardiovascular diseases (CVDs) are the primary cause of mortality in South America, impacting approximately 50% of the population.
  • Temporal trends and epidemiology of cardiomyopathies, adult valve disease, and heart failure (HF) require ongoing assessment for effective healthcare resource allocation and risk reduction strategies.
  • Cerebrovascular disease is the leading cause of death, followed by ischemic heart disease, other heart diseases, and hypertensive disease, with variations observed based on sex and race.

Purpose of the Study:

  • To review the epidemiology of cardiomyopathies, adult valve disease, and heart failure (HF) in South America.
  • To highlight the public health implications for resource allocation and risk reduction strategies.
  • To inform future predictions of cardiovascular disease burden in the region.

Main Methods:

  • Review of existing epidemiological data on cardiovascular diseases in South America.
  • Analysis of mortality and hospitalization data related to specific cardiovascular conditions.
  • Identification of key etiological factors contributing to heart failure.

Main Results:

  • Diseases of the circulatory system are the predominant cause of death.
  • Cerebrovascular disease is the leading cause of death, particularly in women. Race influences cardiovascular mortality rates.
  • Heart failure (HF) is the primary cause for cardiovascular hospital admissions, with ischemic, idiopathic dilated cardiomyopathy, valvular, hypertensive, and chagasic etiologies. Chagas' disease and rheumatic fever are significant contributors to HF and valvular heart disease, respectively.

Conclusions:

  • Heart failure and its associated etiologies account for 6.3% of all deaths.
  • Rheumatic fever is the leading cause of valvular heart disease.
  • Effective public health strategies in South America must incorporate control of Chagas' disease and rheumatic fever to mitigate the burden of heart failure and optimize healthcare resource allocation.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...